ATP10B Inhibitors

Chemical inhibitors of ATP10B can impede its function through various mechanisms, focusing on the protein's dependence on phosphorylation and ATP availability for its activity. Vanadate, a phosphatase inhibitor, can maintain ATP10B in a phosphorylated state, thus preventing its normal function, as ATP10B's activity is regulated by its phosphorylation status. Similarly, Bafilomycin A1, a specific inhibitor of V-ATPases, and Oligomycin, an ATP synthase inhibitor, act to reduce ATP concentrations by targeting cellular machinery responsible for ATP production. Bafilomycin A1 obstructs the proton pump function of V-ATPases, which can lead to the functional inhibition of ATP10B by interfering with its proton gradient-dependent activity. Oligomycin's suppression of ATP synthase can lead to a decrease in cellular ATP levels, which indirectly hampers ATP10B by limiting the energy substrate necessary for its ATPase function.

Additional chemicals such as N-Ethylmaleimide, which alkylates cysteine residues, can disrupt critical disulfide bonds within ATP10B, impeding its structural integrity and hence its function. Thapsigargin and Efrapeptin disrupt calcium and proton gradients, respectively, which are essential for ATP10B's regulatory mechanisms. By altering calcium homeostasis and proton gradients, these inhibitors can indirectly disrupt the proper functioning of ATP10B. Compounds like DCCD and Tributyltin bind directly to the active sites of ATPases, including ATP10B, blocking ATP hydrolysis and thus inhibiting its enzymatic action. Tetrabutylammonium, by compromising the membrane potential, can interfere with ATP10B's reliance on this electrochemical gradient for its activity. Azide and Venturicidin, through their actions on cytochrome c oxidase and ATP synthase, respectively, can decrease ATP production, thereby reducing the availability of ATP for ATP10B and subsequently inhibiting its function. Aurovertin, also by inhibiting ATP synthase, contributes to a decrease in ATP levels, which is crucial for ATP10B's ATPase activity.